Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NDA resubmission for indiplon capsules planned for Q2 2007

Jan. 24, 2007

Progress in phase II trial of AL-208 for MCI in CABG

Jan. 24, 2007

MBP-8298 cleared to begin U.S. phase III study in secondary progressive MS

Jan. 23, 2007

Nalbuphine ER begins phase I safety study for pain

Jan. 23, 2007

Tentative approval for Barr's generic version of Kytril

Jan. 23, 2007

Intravenous cannabinor shows no efficacy benefit in capsaicin-induced pain

Jan. 23, 2007

Inovelon approved in E.U. for Lennox-Gastaut syndrome

Jan. 22, 2007

Recent patents report novel analgesic agents

Jan. 22, 2007

Cipralex approved in Europe for OC

Jan. 22, 2007

Data on nitroflurbiprofen sets stage for clinical trials in DMD

Jan. 22, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...